Based on previous studies, we assigned scores of 100, 200, and 300 for anagen IIIIa, anagen IIIbIIIc, and anagen IVVI HFs, respectively, during telogen-to-anagen transition
TB-500s recovery claims rest on animal data
Circulating BPC-157 dosage protocols often suggest 200500 micrograms per day for 46 weeks in research settings, usually via injection
This review describes the most frequent neurological symptoms associated with WD and their possible treatments
Nasal delivery may be particularly effective in the treatment of neurological diseases due to the direct nose-to-brain pathway
Ongoing Support Beyond the First Visit Your journey doesnt end with the first appointment